...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

In my I-Trade account yesterday .35US

Today .40US

Mine has been fluctuating... likely tied to US OTC....

In my Raymond James account it has shown zero as its value all along!

Share
New Message
Please login to post a reply